A clinical trial to study homoeopathic management of stress in essential hypertension patients in age group of 35-80 years.

Phase 3

Conditions: Health Condition 1: I10- Essential (primary) hypertension

Registration Number: CTRI/2021/06/034396

Lead Sponsor: nil

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1. Patients of both sexes & age group between 35-80 yrs.

2. Patients presenting with pre-diagnosed mild to moderate essential hypertension without any major systemic complications whose exciting or maintaining cause of essential hypertension is identified to be stress.

3. Patients on allopathic treatment for essential hypertension fulfilling above two inclusion criterias will be enrolled.

4. Patients on no allopathic or no homoeopathic treatment (from other doctors for essential hypertension treatment) fulfilling the first

two inclusion criterias will be enrolled.

5. The ability to give informed consent & comply with study procedures.

Exclusion Criteria

1. Pregnant or lactating women with essential hypertension.

2. Patients with severe essential hypertension.

3. Patients with secondary hypertension.

4. Patients who require emergency medical interventions or Severe co-morbidities.

5. Patients on homoeopathic treatment for essential hypertension from another doctor will be excluded.

6. Simultaneous participation in other clinical studies or completion of participation in a study less than 6 months prior (patients are to

be explicitly asked about this).

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Improvement (i.e. Reduction in score after the study) in Perceived Stress Scale Score (PSS) used for stress assessment BEFORE and AFTER the study. <br/ ><br>2. Improvement in SF36 (by RAND) used for Quality of life assessment of the essential hypertension patients BEFORE and AFTER the study.Timepoint: 1. Improvement (i.e. Reduction in score after the study) in Perceived Stress Scale Score (PSS) used for stress assessment at baseline and after 3 months. <br/ ><br>2. Improvement in SF36 (by RAND) used for Quality of life assessment of the essential hypertension patients at baseline and after 3 months.

Secondary Outcome Measures

Name	Time	Method
Improvement in essential hypertension assessed by reduction in levels of blood pressure after 3 months of treatment.Timepoint: Changes in levels of blood pressure at baseline and after 3 months of treatment.